Genesis AI Corp. (CSE: AIG) (OTCQB: AIGFF) (the “Company”) is excited to announce the launch of Wildfire Defence Solutions ...

Genesis AI Corp. (CSE: AIG) (OTCQB: AIGFF) (the "Company") is excited to announce the launch of Wildfire Defence Solutions Version 1.2, a powerful update to the wildfire management tool.

The AI craze has taken the market by storm, dominated by chipmaker Nvidia. Over the last three years, Nvidia stock has ...

Gilead Sciences has struck a deal to work with privately held Genesis Therapeutics to use generative artificial intelligence to discover and develop novel, small-molecule therapies across multiple ...

Genesis Therapeutics specializes in AI-driven small molecule drug discovery ... demonstrated impressive efficacy in the PURPOSE-1 PrEP study, leading RBC Capital to increase its probability ...

Genesis Therapeutics specializes in AI-driven small molecule drug discovery ... The company's HIV prevention drug, lenacapavir, demonstrated impressive efficacy in the PURPOSE-1 PrEP study, leading ...

The global inspection robots market size is estimated to grow by USD 5.70 billion from 2024-2028, according to Technavio. The ...